ClinConnect ClinConnect Logo
Search / Trial NCT01045213

Integrated Care Program for Chronic Obstructive Pulmonary Disease

Launched by UNIVERSITY OF COLORADO, DENVER · Jan 7, 2010

Trial Information

Current as of June 16, 2025

Completed

Keywords

Chronic Obstructive Pulmonary Disease Copd

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • COPD Diagnosis by Gold Guidelines
  • Airflow obstruction on spirometry defined by an FEV1/FVC less than or equal to 70% and an FEV1 less than 50% predicted, or and FEV1 greater than or equal to 50% predicted with a history of a COPD exacerbation within one year, or an FEV1 greater than or equal to 50% predicted and on long-term oxygen therapy.
  • Standard land-line telephone
  • Legal US residency status residing in Adams, Alamosa, Bent, Crowley, Dolores, El Paso, Fremont, Kiowa, Logan, Morgan, Montezuma, Otero, Prowers, Rio Blanco, or Washington counties in Colorado
  • Exclusion Criteria:
  • Asthma
  • Co-existing conditions that are likely to cause death within two years. Patients with CXR evidence of interstitial lung disease, or other pulmonary diagnoses at the time of enrollment, aside from COPD-related bronchiectasis. Patients with end-stage liver, renal or muscle disease, HIV, or a diagnosis of dementia.
  • Participation in another treatment study
  • Inability or unwillingness to cooperate with self-monitoring and reporting components
  • Prisoners, pregnant women, institutionalized patients
  • Current alcohol or drug abuse
  • Non-English speakers
  • Inability to complete a consent
  • Illegal alien, non-Colorado resident, or non-resident of targeted counties

About University Of Colorado, Denver

The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.

Locations

Aurora, Colorado, United States

Patients applied

0 patients applied

Trial Officials

William Vandivier, MD

Principal Investigator

University of Colorado, Denver

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials